Drugs News and Research

RSS

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.

27 May 2004

UK House of Commons Health Committee publishes its long-awaited Report on obesity

Obesity has grown by almost 400% in the last 25 years such that three-quarters of the adult population are now overweight or obese (around 22% are now obese). England has witnessed the fastest growth in obesity in Europe and childhood obesity has tripled in twenty years.

27 May 2004

Brain cells containing the chemical histamine are critical for waking

A study by scientists with the Veterans Affairs' Neurobiology Research Laboratory and UCLA Neuropsychiatric Institute shows that brain cells containing the chemical histamine are critical for waking.

27 May 2004

Need to determine if black cohosh can improve the quality of people’s lives as some claim

It’s a common herb that more than 10 million American women use to ease menopausal symptoms. Its benefits are touted all over the Internet. Yet, the U.S. Food and Drug Administration has not approved it as a drug, and researchers are unsure of its effects on the human body. A University of Missouri-Columbia researcher is hoping to change that.

25 May 2004

New website helps older Texans and disabled get information that may help them obtain their prescription drugs

The Texas Department on Aging has officially launching a "Texas Cares" website -- http://www.txcares.org -- to help older Texans and people with disabilities get information that may help them obtain their prescription drugs.

25 May 2004

Bacteria found in the mouth can block the HIV virus

Certain strains of bacteria that occur naturally in the human mouth can snare the HIV virus and even cells it has infected, according to researchers at the University of Illinois at Chicago College of Dentistry. They report their findings today at the 104th General Meeting of the American Society for Microbiology.

25 May 2004

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Nexxus, the West of Scotland Bioscience Network will hold the second event of the Horizons in Biomedicine Series today at 6.30pm at the Glasgow Science Centre.

25 May 2004

Possible new second-generation multiple sclerosis therapy

Scientists from Genencor International, Inc., have demonstrated in an in vivo model that a new variant of recombinant interferon-beta reduces the immunological response to the protein.

25 May 2004

A new guideline evaluates the treatment of infantile spasms

A new guideline developed by the American Academy of Neurology and the Child Neurology Society evaluates the treatment of infantile spasms. The guideline is published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

In a small study conducted at the U.S. National Institutes of Health (NIH), researchers have shown that it may be feasible to treat HIV-infected patients with a simple, once-daily regimen of anti-HIV drugs given in pre-planned, 7-day-on, 7-day-off cycles.

24 May 2004

Racial differences in treatment of back pain

A UC Riverside study found that African-Americans and Latinos seeking treatment for back pain were prescribed pain relievers less often than were white patients.

24 May 2004

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Vertex Pharmaceuticals Incorporated has announced that it has expanded its drug discovery and development collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation.

24 May 2004

Medicare Drug Discount Card pricing is lower than internet and mail-order pharmacy prices

A new study by the Centers for Medicare & Medicaid Services (CMS) found that prices available from Medicare-Approved Drug Discount Cards are lower than current Internet and mail-order pharmacy prices.

24 May 2004

Innovative new cancer drug enters the first phase of clinical trials

An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.

24 May 2004

Call to bring cancer genomics from the lab bench into large-scale clinical trials

Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.

24 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Scientists have genetically engineered a mouse with extraordinary resistance to bowel cancer

Scientists have genetically engineered a mouse with extraordinary resistance to bowel cancer, delegates at the Cancer Research UK senior researchers' conference in Harrogate will hear today.

24 May 2004

Fifteen Australian lives were saved in one month as a result of pharmacists intervening in medicine management

The study, published in the British Journal of Clinical Pharmacology, also revealed that 88 pharmacist interventions reduced the length of patient stays in hospital and 156 interventions reduced the potential for the patient to be readmitted to hospital.

24 May 2004

Combination therapy may be useful in humans with spinal cord injury

A combination therapy using transplanted cells plus two experimental drugs significantly improves function in paralyzed rats, a new study shows. The results suggest that a similar therapy may be useful in humans with spinal cord injury.

23 May 2004

Increases in co-payments may reduce the use of medications

Significant increases in co-payments may reduce the use of medications and raise concern about adverse health consequences, according to a study published in the May 19 issue of the Journal of the American Medical Association (JAMA).

22 May 2004

Drugs News and Research

Human Genome Sciences has begun dosing patients with chronic hep C drug

UK House of Commons Health Committee publishes its long-awaited Report on obesity

Brain cells containing the chemical histamine are critical for waking

Need to determine if black cohosh can improve the quality of people’s lives as some claim

New website helps older Texans and disabled get information that may help them obtain their prescription drugs

Bacteria found in the mouth can block the HIV virus

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Possible new second-generation multiple sclerosis therapy

A new guideline evaluates the treatment of infantile spasms

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

Racial differences in treatment of back pain

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Medicare Drug Discount Card pricing is lower than internet and mail-order pharmacy prices

Innovative new cancer drug enters the first phase of clinical trials

Call to bring cancer genomics from the lab bench into large-scale clinical trials

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Scientists have genetically engineered a mouse with extraordinary resistance to bowel cancer

Fifteen Australian lives were saved in one month as a result of pharmacists intervening in medicine management

Combination therapy may be useful in humans with spinal cord injury

Increases in co-payments may reduce the use of medications

Drug Discovery - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News